The new logo is a refreshing change from the version that has served Hetero well for three decades. And yet its reflection can be seen in the new version
Company's net income rose by 57.5 percent to 3.291 billion euros in Q1
Myovant to receive an upfront payment of US $50 million, is eligible to receive commercial launch, sales-based and other milestones totaling up to US $90.5 million
RNA extraction free kit to deliver results in just 45 minutes
Glenmark's current portfolio consists of 174 products authorized for distribution in the U.S. marketplace and 48 ANDA's pending approval with the USFDA
To lay a technological foundation for developing exosome-based medicines and cosmetic products for dermatitis treatment
The plan is to advance innovative therapies to drug-resistant cancers
SCG101 is an autologous T-cell receptor (TCR) T-cell therapy for liver cancer
He was previously working as the CEO of IVD business at Trivitron Healthcare and drove its growth through innovation
The department will soon release a policy to catalyze research & development and innovation in the pharma- Medtech sector in India
Subscribe To Our Newsletter & Stay Updated
